Massachusetts General Hospital
Boston, MA
Overview:
Somatic mutations indicative of clonal hematopoiesis have emerged as a novel risk factor for atherosclerotic cardiovascular disease. This talk will cover its discovery, biology, and clinical implications for the prevention and atherosclerotic cardiovascular disease.
Objectives:
At the conclusion of the activity a participant should be able to:
- Recognize the role of somatic mutations indicative of clonal hematopoiesis in cardiovascular disease risk.
- Identify opportunities for mitigating excess cardiovascular disease risk attributed to clonal hematopoiesis.
- Identify individuals for whom clonal hematopoiesis screening may be useful.
Disclosures:
Pradeep Natarajan, MD is an consultant or received a grant for Allelica, Blackstone Life Sciences, Foresite Labs, Genentech, GV, Novartis. He was consultant or received a grant for Apple, Amgen, AstraZeneca, Boston Scientific, and Heartflow. Dr. Natarajan is also an advisor or has equity with Esperion Therapeutics, Preciseli, TenSixteen Bio. He also has spousal employment with Vertex.
The Planning Committee has nothing to disclose relevant to this program.
The THI CME Staff has nothing to disclose relevant to this program.
The Program Reviewers has nothing to disclose relevant to this program.
All relevant financial relationships have been mitigated.
The Texas Heart Institute Grand Rounds is an esteemed tradition that attracts leading experts from around the world each year.
Series attendees include Cardiology Fellows and Faculty, members of the Departments of Internal Medicine and Cardiovascular Surgery, as well as visitors from other clinical and teaching institutions in the Texas Medical Center. We live broadcast Grand Rounds for online viewing on any desktop computer or mobile device.
Live Webcasting
Register for Livestream and Reminders (Required to receive link by email)
2022-23 Faculty Schedule
2022-23 Grand Rounds Event Calendar
Obtain CME Credit
Accreditation and Credit Designation
The Texas Heart Institute is accredited by the Accreditation Council or Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Texas Heart Institute designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Visit THI CME Portal
Questions? Contact CME@texasheart.org
